- Novavax COVID-19 Data Presented at FDA VRBPAC Meeting Demonstrates Broad Antibody Responses to Both Prototype and Omicron-Specific Variants https://ir.novavax.com/2022-06-28-Novavax-COVID-19-Data-Presented-at-FDA-VRBPAC-Meeting-Demonstrates-Broad-Antibody-Responses-to-Both-Prototype-and-Omicron-Specific-Variants 6 comments science
- $NVAX Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies https://ir.novavax.com/2021-12-22-Novavax-Announces-Initial-Omicron-Cross-Reactivity-Data-from-COVID-19-Vaccine-Booster-and-Adolescent-Studies 3 comments wallstreetbets
- Update from the Scientist who posted original NVAX DD: NVAX reports best efficacy to date against original COVID variant (95.6%) and remains massively undervalued 🚀🚀🚀🚀🚀🚀 https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3 151 comments wallstreetbets
- Ακόμα ένα αποτελεσματικό εμβόλιο που ΔΕΝ εξασφάλισε η Ευρώπη αλλά το ΗΒ https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3 8 comments greece
- NVAX releases awesome positive phase 3 data -$NVAX to the moon https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3 14 comments wallstreetbets
- Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial | Novavax Inc. - IR Site https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3 109 comments europe
- Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3 8 comments worldnews